Galenic Pharmaceticals Private Limited
Founded in 2006 and headquartered in Telangana, India.
2006 | Hyderabad, Telangana (India) | Active
Galenic Pharmaceticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.20 M
- Company Age 18 Year, 7 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 5.00 M
About Galenic Pharmaceticals
Galenic Pharmaceticals Private Limited (GPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 July 2006 and has a history of 18 years and seven months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.20 M.
The company currently has active open charges totaling ₹5.00 M.
Rajendra Jaiswal, Mukesh Sawhney, and Jayant Sapkal serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239TG2006PTC050703
- Company No.
050703
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jul 2006
- Date of AGM
30 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Trading
Who are the key members and board of directors at Galenic Pharmaceticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukesh Sawhney  | Managing Director | 24-Jul-2006 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajendra Jaiswal | Director | 24-Jul-2006 | Current |
| Jayant Sapkal | Whole-Time Director | 24-Jul-2006 | Current |
Financial Performance of Galenic Pharmaceticals.
Enhance accessibility to Galenic Pharmaceticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Galenic Pharmaceticals?
Unlock access to Galenic Pharmaceticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹5.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- The Akola Urban Co-Op Bank Ltd : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jul 2007 | The Akola Urban Co-Op Bank Ltd | ₹5.00 M | Open |
How Many Employees Work at Galenic Pharmaceticals?
Unlock and access historical data on people associated with Galenic Pharmaceticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Galenic Pharmaceticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Galenic Pharmaceticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
